Johnson Controls Inc Q2 adjusted earnings Beat Estimates
Johnson Controls Inc (JCI) reported earnings for its second quarter that increased from last year.
The company’s earnings totaled $343 million, or $0.48 per share. This compares with $213 million, or $0.28 per share, in last year’s second quarter.
Excluding items, Johnson Controls Inc reported adjusted earnings of $373 million or $0.52 per share for the period.
Analysts had expected the company to earn $0.49 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.
The company’s revenue for the quarter rose 2.8% to $5.59 billion from $5.44 billion last year.
Johnson Controls Inc earnings at a glance:
-Earnings (Q2): $373 Mln. vs. $317 Mln. last year.
-EPS (Q2): $0.52 vs. $0.42 last year.
-Analysts Estimate: $0.49
-Revenue (Q2): $5.59 Bln vs. $5.44 Bln last year.
Next quarter EPS guidance: $0.80 to $0.82
Full year EPS guidance: $2.58 to $2.65
Oppenheimer Holdings Inc. Q1 Earnings Advance
Oppenheimer Holdings Inc. (OPY) released a profit for its first quarter that increased from last year.
The company’s bottom line came in at $38.66 million, or $2.91 per share. This compares with $7.82 million, or $0.58 per share, in last year’s first quarter.
The company’s revenue for the quarter rose 59.0% to $373.28 million from $234.77 million last year.
Oppenheimer Holdings Inc. earnings at a glance:
-Earnings (Q1): $38.66 Mln. vs. $7.82 Mln. last year.
-EPS (Q1): $2.91 vs. $0.58 last year.
-Revenue (Q1): $373.28 Mln vs. $234.77 Mln last year.
Exxon posts first profit in five quarters on higher oil prices
April 30 (Reuters) – Top U.S. oil producer Exxon Mobil Corp on Friday posted its first profit in five quarters, as higher oil and gas prices offset costs from a deep freeze in February.
Net income attributable to Exxon was $2.73 billion, or 64 cents per share, in the first quarter, compared with a loss of $610 million, or 14 cents per share, a year earlier.
Bell Acquires Octane Racing Group For Undisclosed Terms
Canadian telecommunications and media company, Bell Canada (BCE.TO, BCE) has acquired Montréal’s Octane Racing Group Inc., promoter of the Formula 1 Canadian Grand Prix, the largest annual sports and tourism event in the country, Bell said in a release.
Financial terms of the deal were not disclosed.
Octane Racing Group will continue as a standalone entity within the Bell group of companies to promote the Formula 1 Canadian Grand Prix. Octane President and CEO François Dumontier and all Octane employees join Bell effective today, Bell said.
Following cancellation of two consecutive years’ Grand Prix events in Montréal due to the pandemic, the tickets already purchased in 2020 will be valid for 2022, or will be refunded if the ticket holders wish so.
The company expects that the two additional editions of the Montreal race, to be held in 2030 and 2031 as a compensation for 2020 and 2021 cancellations, will bring enhanced commercial opportunities for both Bell and F1.
“The Formula 1 Canadian Grand Prix is the biggest sporting and touristic event in the country, and it seemed only natural for us to join forces with Bell to help elevate the event to its fullest potential,” said François Dumontier. “With Bell’s assets and commitment to develop the event, the future of Montréal’s leg of the Formula 1 World Championship just got better. I am thankful to have the opportunity to continue to follow my passion with Formula 1 and to be able to develop new opportunities for the Formula 1 Canadian Grand Prix with the support of a company so well established in Québec and across Canada.”
Pfizer, BioNTech Submit Request In EU To Authorize Covid Vaccine To Adolescents
Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have submitted a request to expand conditional marketing authorization or CMA of their Covid vaccine Comirnaty (BNT162b2) in the European Union to adolescents.
The companies submitted a variation to the CMA in the EU to the European Medicines Agency or EMA to request an extension of the indication for use in adolescents 12 to 15 years of age. If EMA approves the variation, the amended CMA will be valid in all 27 member states of the EU.
The companies have already submitted a similar request to the U.S. Food and Drug Administration for the Emergency Use Authorization or EUA. They also plan to request additional amendments with other regulatory authorities worldwide.
Comirnaty has already been granted CMA by the European Commission to prevent COVID-19 in people from 16 years of age.
The latest submission is based on data from a pivotal Phase 3 clinical trial, which enrolled 2,260 participants aged 12 to 15 years. Topline results from this trial showed a vaccine efficacy of 100% in participants with or without prior SARS-CoV-2 infection and robust antibody responses.
In the trial, the vaccine also was generally well tolerated. Participants in the trial will continue to be monitored for long-term protection and safety for an additional two years after their second dose.
Illinois Tool Works Boosts FY21 Outlook – Quick Facts
While reporting financial results for the first quarter on Friday, Illinois Tool Works, Inc. (ITW) raised its earnings, revenue and organic revenue guidance for the full-year 2021, based on demand rates exiting the first quarter.
For fiscal 2021, the company now projects earnings in the range of $8.20 to $8.60 per share on revenue growth of 12 to 14 percent, with organic revenue growth of 10 to 12 percent.
Previously, the company expected earnings in the range of $7.60 to $8.00 per share on revenue growth of 9 to 12 percent, with organic revenue growth of 7 to 10 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.96 per share on revenue growth of 11.5 percent to $14.02 billion for the year. Analysts’ estimates typically exclude special items.
The company also said it plans to repurchase approximately $1 billion of its shares.